Identifier |
Protein names |
Gene names |
Cross reference refseq |
Length |
Species |
A0A023QJS4
|
Cytochrome b;
|
CYTB;
|
NULL
|
380
|
human
|
B4YD74
|
Cytochrome b;
|
CYTB;
|
NULL
|
378
|
human
|
D3DRD4
|
Fibroblast growth factor receptor; EC 2.7.10.1;
|
FGFR2;
|
NULL
|
724
|
human
|
B4DK89
|
cDNA FLJ60623, highly similar to tRNA isopentenyltransferase, mitochondrial; EC 2.5.1.8; tRNA dimethylallyltransferase, mitochondrial;
|
TRIT1;
|
NULL
|
143
|
human
|
C9D5R1
|
NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3;
|
ND4;
|
NULL
|
459
|
human
|
E5KMK5
|
Mitochondrial DNA topoisomerase I;
|
NULL
|
NULL
|
601
|
human
|
B9TX21
|
Mediator complex subunit MED16 variant MED16_i28; Mediator of RNA polymerase II transcription subunit 16;
|
MED16;
|
NULL
|
135
|
human
|
Q6R0X2
|
NADH-ubiquinone oxidoreductase chain 1; EC 1.6.5.3;
|
ND1;
|
NULL
|
318
|
human
|
Q9H4C5
|
E3 ubiquitin-protein ligase Mdm2; p53-binding protein;
|
MDM2;
|
NULL
|
243
|
human
|
A0SBN6
|
NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3;
|
ND5;
|
NULL
|
603
|
human
|
X5C5Z6
|
NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3;
|
ND2;
|
NULL
|
347
|
human
|
Q6VIF8
|
NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3;
|
ND2; NADH2 ndh2;
|
NULL
|
347
|
human
|
A8QTM8
|
NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3;
|
ND5;
|
NULL
|
603
|
human
|
C1K3N0
|
Transcription factor AP-2 alpha; Transcription factor AP-2-alpha;
|
TFAP2A;
|
NULL
|
328
|
human
|
Q2LHC6
|
NADH-ubiquinone oxidoreductase chain 2; EC 1.6.5.3;
|
ND2;
|
NULL
|
347
|
human
|
Q4GMK4
|
NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3;
|
NADH5; ND5;
|
NULL
|
603
|
human
|
U3M2W8
|
NADH-ubiquinone oxidoreductase chain 5; EC 1.6.5.3;
|
ND5;
|
NULL
|
603
|
human
|
G9LFX9
|
NADH-ubiquinone oxidoreductase chain 4; EC 1.6.5.3;
|
ND4;
|
NULL
|
459
|
human
|
A0A059S7J4
|
Cytochrome b;
|
CYTB;
|
NULL
|
380
|
human
|
D0EV56
|
MHC class II antigen;
|
HLA-DRB1;
|
NULL
|
266
|
human
|